Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

    Appelbaum FR, Barrall J, Storb R, Fisher LD, Schoch G, Ramberg RE, Shulman H, Anasetti C, Bearman SI, Beatty P, et al.

    Ann Intern Med. 1990 Apr 15;112(8):590-7.PMID: 2183666 [PubMed - indexed for MEDLINE]Related articles

    2.

    Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.

    Anderson JE, Appelbaum FR, Fisher LD, Schoch G, Shulman H, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Doney K, et al.

    Blood. 1993 Jul 15;82(2):677-81.PMID: 8329721 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.

    Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey T, Clift RA, et al.

    J Clin Oncol. 1996 Jan;14(1):220-6.PMID: 8558201 [PubMed - indexed for MEDLINE]Related articles

    5.

    Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.

    Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F, et al.

    Blood. 1995 May 1;85(9):2354-63.PMID: 7727769 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

    Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM.

    Blood. 2002 Sep 15;100(6):1997-2004.PMID: 12200358 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    An update on allogeneic marrow transplantation for myelodysplastic syndrome.

    Anderson JE, Appelbaum FR, Storb R.

    Leuk Lymphoma. 1995 Mar;17(1-2):95-9.PMID: 7773167 [PubMed - indexed for MEDLINE]Related articles

    8.

    Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.

    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.

    Bone Marrow Transplant. 1996 May;17(5):685-9.PMID: 8733682 [PubMed - indexed for MEDLINE]Related articles

    9.

    Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.

    Witherspoon RP, Deeg HJ.

    Haematologica. 1999 Dec;84(12):1085-7.PMID: 10586209 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.

    Bone Marrow Transplant. 1998 Feb;21(3):255-61.PMID: 9489648 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

    Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR.

    Bone Marrow Transplant. 2001 Oct;28(7):643-7.PMID: 11704786 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Predictive value of pulmonary function tests before marrow transplantation.

    Crawford SW, Fisher L.

    Chest. 1992 May;101(5):1257-64.PMID: 1582281 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

    Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W, McDonald GB, Mori M, Schoch G, Hansen JA.

    J Clin Oncol. 1993 Feb;11(2):304-13.PMID: 8426208 [PubMed - indexed for MEDLINE]Related articles

    15.

    Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.

    Ratanatharathorn V, Karanes C, Uberti J, Lum LG, de Planque MM, Schultz KR, Cronin S, Dan ME, Mohamed A, Hussein M, et al.

    Blood. 1993 Apr 15;81(8):2194-9.PMID: 8471779 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.

    Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.PMID: 9209736 [PubMed - indexed for MEDLINE]Related articles

    17.

    Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.

    Corvò R, Paoli G, Barra S, Bacigalupo A, Van Lint MT, Franzone P, Frassoni F, Scarpati D, Bacigalupo A, Vitale V.

    Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):497-503.PMID: 10078628 [PubMed - indexed for MEDLINE]Related articles

    18.

    Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.

    Sutton L, Chastang C, Ribaud P, Jouet JP, Kuentz M, Attal M, Reiffers J, Tigaud JM, Rio B, Dauriac C, Legros M, Dreyfus F, Lioure B, Troussard X, Milpied N, Witz F, Oriol P, Cahn JY, Michallet M, Gluckman E, Ifrah N, Pico JL, Vilmer E, Leblond V.

    Blood. 1996 Jul 1;88(1):358-65.PMID: 8704196 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

    Ringdén O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Mellander L, Ljungman P, Jacobsen N.

    Blood. 1999 Apr 1;93(7):2196-201.PMID: 10090927 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Bone marrow transplantation for thalassemia. The USA experience.

    Walters MC, Sullivan KM, O'Reilly RJ, Boulad F, Brockstein J, Blume K, Amylon M, Johnson FL, Klemperer M, Graham-Pole J, et al.

    Am J Pediatr Hematol Oncol. 1994 Feb;16(1):11-7. Erratum in: Am J Pediatr Hematol Oncol 1994 May;16(2):189. PMID: 8311166 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data